Skip to main content
. 2014 Mar 19;2014:758212. doi: 10.1155/2014/758212

Figure 2.

Figure 2

Kaplan-Meier plots showing time-to-discontinuation (all causality, due to lack of efficacy, and due to adverse events) for intent-to-treat (ITT) patients with schizophrenia in pomaglumetad methionil (N = 511) and aripiprazole (N = 161) treatment groups for 24 weeks of double-blind treatment.